skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 305  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
Material Type:
Article
Add to My Research

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

The Lancet (British edition), 2022-11, Vol.400 (10365), p.1788-1801 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02074-8 ;PMID: 36351458

Full text available

2
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Material Type:
Article
Add to My Research

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet (British edition), 2019-01, Vol.393 (10166), p.31-39 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32590-X ;PMID: 30424892

Full text available

3
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-01, Vol.385 (9965), p.341-350 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 24, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61374-X ;PMID: 25282520 ;CODEN: LANCAO

Full text available

4
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Material Type:
Article
Add to My Research

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

The New England journal of medicine, 2015-04, Vol.372 (16), p.1500-1509 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1500858 ;PMID: 25773607

Full text available

5
Clinical evidence for oral antiplatelet therapy in acute coronary syndromes
Material Type:
Article
Add to My Research

Clinical evidence for oral antiplatelet therapy in acute coronary syndromes

The Lancet (British edition), 2015-07, Vol.386 (9990), p.292-302 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 18, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)60213-6 ;PMID: 25777663 ;CODEN: LANCAO

Full text available

6
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Material Type:
Article
Add to My Research

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

The New England journal of medicine, 2022-11, Vol.387 (20), p.1855-1864 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2211023 ;PMID: 36342163

Full text available

7
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
Material Type:
Article
Add to My Research

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

The Lancet (British edition), 2010-10, Vol.376 (9749), p.1312-1319 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 16-Oct 22, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61273-1 ;PMID: 20801494 ;CODEN: LANCAO

Full text available

8
The China Acute Myocardial Infarction (CAMI) Registry: A National Long-term Registry-Research-Education Integrated Platform for Exploring Acute Myocardial Infarction in China
Material Type:
Article
Add to My Research

The China Acute Myocardial Infarction (CAMI) Registry: A National Long-term Registry-Research-Education Integrated Platform for Exploring Acute Myocardial Infarction in China

The American heart journal, 2016-05, Vol.175, p.193-201.e3 [Peer Reviewed Journal]

2015 The Authors ;Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 2016 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2015.04.014 ;PMID: 27179740 ;CODEN: AHJOA2

Full text available

9
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction
Material Type:
Article
Add to My Research

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Journal of the American College of Cardiology, 2015-05, Vol.65 (20), p.2211-2221 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2015 American College of Cardiology Foundation ;Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 26, 2015 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.03.003 ;PMID: 25787199

Full text available

10
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Material Type:
Article
Add to My Research

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9665), p.723-731 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Feb 28-Mar 6, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60441-4 ;PMID: 19249633 ;CODEN: LANCAO

Full text available

11
Platelet functions beyond hemostasis
Material Type:
Article
Add to My Research

Platelet functions beyond hemostasis

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1759-1766 [Peer Reviewed Journal]

2009 International Society on Thrombosis and Haemostasis ;ISSN: 1538-7933 ;ISSN: 1538-7836 ;EISSN: 1538-7836 ;DOI: 10.1111/j.1538-7836.2009.03586.x ;PMID: 19691483

Full text available

12
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
Material Type:
Article
Add to My Research

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial

The American heart journal, 2018-06, Vol.200, p.83-89 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 2018 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2018.01.012 ;PMID: 29898853

Full text available

13
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study
Material Type:
Article
Add to My Research

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study

Diabetes care, 2020-02, Vol.43 (2), p.468-475 [Peer Reviewed Journal]

2019 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1476 ;PMID: 31843945

Full text available

14
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
Material Type:
Article
Add to My Research

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

The American heart journal, 2007, Vol.153 (1), p.66.e9-66.e16 [Peer Reviewed Journal]

2007 ;Copyright Elsevier Limited Jan 2007 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2006.10.010 ;PMID: 17174640 ;CODEN: AHJOA2

Full text available

15
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE
Material Type:
Article
Add to My Research

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE

Circulation (New York, N.Y.), 2023-04, Vol.147 (16), p.1192-1203 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circulationaha.122.063399 ;PMID: 36779348

Full text available

16
DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction
Material Type:
Article
Add to My Research

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction

Journal of the American College of Cardiology, 2016-05, Vol.67 (21), p.2492-2502 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2016 American College of Cardiology Foundation ;Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 31, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.03.485 ;PMID: 27046159

Full text available

17
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
Material Type:
Article
Add to My Research

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

The Lancet (British edition), 2009-09, Vol.374 (9694), p.989-997 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;Copyright Elsevier Limited Sep 19-Sep 25, 2009 ;Copyright Elsevier Limited Sep 19, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61525-7 ;PMID: 19726078 ;CODEN: LANCAO

Full text available

18
Response by Kato et al to Letter Regarding Article, “Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus”
Material Type:
Article
Add to My Research

Response by Kato et al to Letter Regarding Article, “Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus”

Circulation (New York, N.Y.), 2019-10, Vol.140 (18), p.e740-e741 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.042848 ;PMID: 31657959

Full text available

19
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
Material Type:
Article
Add to My Research

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial

European heart journal, 2009-07, Vol.30 (14), p.1753-1763 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org 2009 ;2009 INIST-CNRS ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehp159 ;PMID: 19435740

Full text available

20
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
Material Type:
Article
Add to My Research

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial

The Lancet (British edition), 2008-04, Vol.371 (9621), p.1353-1363 [Peer Reviewed Journal]

Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Apr 19-Apr 25, 2008 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)60422-5 ;PMID: 18377975 ;CODEN: LANCAO

Full text available

Results 1 - 20 of 305  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (295)

Refine My Results

Creation Date 

From To
  1. Before 2002  (7)
  2. 2002 To 2006  (34)
  3. 2007 To 2011  (87)
  4. 2012 To 2017  (82)
  5. After 2017  (96)
  6. More options open sub menu

Language 

  1. English  (304)
  2. Japanese  (31)
  3. Russian  (2)
  4. More options open sub menu

Searching Remote Databases, Please Wait